Zobrazeno 1 - 10
of 34
pro vyhledávání: '"M Jennifer Abuzzahab"'
Autor:
Anupam Kharbanda, Kelly R Bergmann, Ling Zhong, Dave Watson, Petter Bjornstad, M Jennifer Abuzzahab, Elizabeth Collins-Dippel, Amanda Nickel
Publikováno v:
BMJ Open, Vol 14, Iss 6 (2024)
Introduction Approximately 40% of children with diabetic ketoacidosis (DKA) develop acute kidney injury (AKI), which increases the risk of chronic kidney damage. At present, there is limited knowledge of racial or ethnic differences in diabetes-relat
Externí odkaz:
https://doaj.org/article/a4d9cab477e34146901224c0a661232a
Autor:
Merlin G. Butler, Bradley S. Miller, Alicia Romano, Judith Ross, M. Jennifer Abuzzahab, Philippe Backeljauw, Vaneeta Bamba, Amrit Bhangoo, Nelly Mauras, Mitchell Geffner
Publikováno v:
Frontiers in Endocrinology, Vol 13 (2022)
Noonan, Turner, and Prader-Willi syndromes are classical genetic disorders that are marked by short stature. Each disorder has been recognized for several decades and is backed by extensive published literature describing its features, genetic origin
Externí odkaz:
https://doaj.org/article/be5ba1ffb43a4445bee8749412bcebc7
Publikováno v:
Pediatric Emergency Care. 39:67-73
Autor:
Ashley H. Shoemaker, Heidi J. Silver, Maciej Buchowski, James C. Slaughter, Jack A. Yanovski, Clinton Elfers, Christian L. Roth, M. Jennifer Abuzzahab
Publikováno v:
International Journal of Obesity. 46:623-629
Autor:
Alberto Pietropoli, Nicky Kelepouris, Vlady Ostrow, Moris Angulo, Maithé Tauber, M. Jennifer Abuzzahab
Publikováno v:
International Journal of Pediatric Endocrinology, Vol 2020, Iss 1, Pp 1-8 (2020)
International Journal of Pediatric Endocrinology
International Journal of Pediatric Endocrinology, BioMed Central, 2020, 2020 (1), pp.20. ⟨10.1186/s13633-020-00090-6⟩
International Journal of Pediatric Endocrinology
International Journal of Pediatric Endocrinology, BioMed Central, 2020, 2020 (1), pp.20. ⟨10.1186/s13633-020-00090-6⟩
BackgroundGrowth hormone (GH) deficiency is common in patients with Prader-Willi syndrome (PWS) and leads to short adult stature. The current study assessed clinical outcomes based on real-world observational data in pediatric patients with PWS who w
Autor:
M. Jennifer Abuzzahab, Jack A. Yanovski, Clinton Elfers, Christian L. Roth, Ashley H. Shoemaker, Kathryn B. Whitlock, Francisco A. Perez
Publikováno v:
Diabetes, Obesity & Metabolism
Aim To evaluate the efficacy, safety and tolerability of a glucagon‐like peptide‐1 receptor agonist (GLP‐1 RA) in patients with hypothalamic obesity (HO). Materials and Methods A two‐arm, randomized, multicentre, double‐blind, placebo‐con
Autor:
Ashley H, Shoemaker, Heidi J, Silver, Maciej, Buchowski, James C, Slaughter, Jack A, Yanovski, Clinton, Elfers, Christian L, Roth, M Jennifer, Abuzzahab
Publikováno v:
International journal of obesity (2005). 46(3)
Hypothalamic obesity (HO) frequently occurs following suprasellar tumors from a combination of decreased energy expenditure and increased energy intake. Glucagon-like peptide-1 receptor agonist (GLP1RA) therapy is associated with increased satiety an
Publikováno v:
Hormone Research in Paediatrics. 91:128-136
Hypothalamic obesity (HO) frequently occurs following damage to the medial hypothalamic region, encompassing the arcuate nucleus, the paraventricular nucleus, the ventromedial nucleus, the dorsomedial nucleus, and the dorsal hypothalamic area, which
Autor:
Francisco A. Perez, M. Jennifer Abuzzahab, Jack A. Yanovski, Clinton Elfers, Christian L. Roth, Ashley H. Shoemaker
Publikováno v:
Diabetes Obes Metab
AIM To evaluate whether neuroimaging-delineated regions of hypothalamic injury are associated with a differential treatment response to a glucagon-like peptide-1 receptor agonist (GLP-1RA) in patients with hypothalamic obesity (HO). MATERIALS AND MET